Recent Advances in Cancer Pain Management

References

• Foley KM. The treatment of cancer pain. N Engl J Med 1985; 313: 84–95
   PubMed Web of Science ®Google Scholar
• Foley KM. Pain syndromes in patients with cancer. Med Clin North Am 1987; 71(2)169–184
   PubMed Web of Science ®Google Scholar
• Portenoy RK. Cancer pain: Epidemiology and syndromes. Cancer 1989; 63: 2298–2307
   PubMed Web of Science ®Google Scholar
• Payne R. Pathophysiology of cancer pain. Advances in Pain Research and Therapy, KM. Foley, et al. Raven Press, New York 1990; Vol. 16
   Google Scholar
• Kanner RM, Foley KM. Patterns of narcotic drug use in a cancer pain clinic. Ann NY Acad Sci 1982; 362: 161–172
   Google Scholar
• Hanks GW. The pharmacological treatment of bone pain. Cancer Surv 1988; 7: 87–101
   PubMedGoogle Scholar
• Portenoy RK, Hagen NA. Breakthrough pain: Definition, prevalence and characteristics. Pain 1990; 41: 273–281
   PubMed Web of Science ®Google Scholar
• Rogers AG. How to manage incident pain. J Pain Symptom Management 1987; 2(2)99
   PubMedGoogle Scholar
• Max MB. Towards physiologically based treatment of patients with neuropathic pain. Pain 1990; 42(2)131–137
   PubMed Web of Science ®Google Scholar
• Tasker RR. Deafferentation. Textbook of Pain, PD. Wall, R. Melzack. Churchill Livingstone, Edinburgh 1984; 119–132
   Google Scholar
• Bourea F, Doubrere JF, Luu M. Study of verbal description in neuropathic pain. Pain 1990; 42(2)145–152
   PubMed Web of Science ®Google Scholar
• Tada K, Nakashima H, Yoshida T, Kitano K. A new treatment of painful amputation neuroma: A preliminary report. J Hand Surg Br 1987; 12(2)273–276
   PubMedGoogle Scholar
• Raj PP. Cryoanalgesia. Practical Pain Management. Year Book Medical Publishers, Chicago. London 1986
   Google Scholar
• Sherman RA. Stump and phantom limb pain. Neurol Clin 1989; 7(2)249–264
   PubMed Web of Science ®Google Scholar
• Kori S, Foley KM, Posner JB. Brachial plexus lesions in patients with cancer: Clinical findings in 100 cases. Neurology 1981; 31: 45–50
   PubMed Web of Science ®Google Scholar
• Kanner RM, Martini N, Foley KM. Incidence of pain and other clinical manifestations of superior pulmonary sulcus tumor (Pan-coast's tumors). Advances in Pain Research and Therapy, JJ. Bonica. Raven Press, Ventafridda, CA Pagni, New York 1982; Vol. 4: 27–38
   Google Scholar
• Filshie J. The non-drug treatment of neuralgic and neuropathic pain of malignancy. Cancer Surv 1988; 7(1)161–193
   PubMedGoogle Scholar
• Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988; 33(1)11–23
   PubMed Web of Science ®Google Scholar
• Mucke L, Maciewicz R. Clinical management of neuropathic pain. Neurol Clin 1987; 5(4)619–663
   Google Scholar
• McQuay HJ. Pharmacological treatment of neuralgic and neuropathic pain. Cancer Surv 1988; 7(1)141–159
   PubMedGoogle Scholar
• Getto CJ, Sorkness CA, Howell T. Antidepressants and chronic nonmalignant pain: A review. J Pain Symptom Management 1987; 2: 9–18
   PubMedGoogle Scholar
• Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37: 589–594
   PubMed Web of Science ®Google Scholar
• Swerdlow M. Anticonvulsant drugs and chronic pain. Clin Neuropharmacol 1984; 7: 51–82
   PubMed Web of Science ®Google Scholar
• Abram SE. Pain of sympathetic origin. Practical Management of Pain, PP. Raj. Year Book Medical Publishers, Chicago 1986; 451–463
   Google Scholar
• Bruera E, MacMillan K, Hanson J, MacDonald RN. The Edmonton staging system for cancer pain: Preliminary report. Pain 1989; 37: 203–209
   PubMed Web of Science ®Google Scholar
• Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975; 1: 277–299
   PubMed Web of Science ®Google Scholar
• Tearnan BH, Cleeland CS. Unaided use of pain descriptors by patients with cancer pain. J Pain Symptom Management 1990; 5(4)228–232
   PubMedGoogle Scholar
• Wilkie D, Lovejoy N, Dodd M, Tesler M. Cancer pain intensity measurement: Concurrent validity of three tools—Finger dynamometer. pain intensity number scale, visual analogue scale. Hospice J 1990; 6(1)1–13
   PubMedGoogle Scholar
• Kaiko RF. Age and morphine analgesia in cancer patients with postoperative pain. Clin Pharmacol Ther 1980; 28: 823–826
   PubMed Web of Science ®Google Scholar
• Jaffe JH, Martin WR. Opioid analgesics and antagonists. Goodman & Gilman's The Pharmacological Baais of Therapeutics. Macillan, New York 1985; 494–534
   Google Scholar
• Neal EA, Meffin PJ, Gregory PB, Blaschke TF. Enhanced bio-availability and decreased clearance of analgesics in patients with cirrhosis. Gastroenterology 1979; 77: 96–102
   PubMed Web of Science ®Google Scholar
• Kaiko RF, Foley KM, Grabinski PY, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983; 13: 180–185
   PubMed Web of Science ®Google Scholar
• Massie MJ, Holland JC. The cancer patient with pain: Psychiatric complications and their management. Med Clin North Am 1987; 71(2)243–258
   PubMed Web of Science ®Google Scholar
• Kanner RM, Cooper ES. Availability of narcotic analgesics for ambulatory patients with pain. Advances in Pain Research and Therapy, CS. Hill, Jr, WS. Fields. Raven Press, New York 1989; Vol. 11
   Google Scholar
• Ventafridda V, Tamburini M, Caraceni A, De Conno F, Maldi F. A validation atudy of the WHO method for cancer pain relief. Cancer 1987; 58: 850–856
   Google Scholar
• Ventafridda V, Saita L, Barletta L, Sbanotto A, DeConno F. Clinical observations on controlled-release morphine in cancer pain. J Pain Symptom Management 1989; 4(3)124–129
   PubMedGoogle Scholar
• Lapin J, Portenoy RK, Coyle N, Houde RW, Foley KM. Guidelines for use of controlled-release oral morphine in cancer pain management. Correlation with clinical experience. Cancer Nurs 1989; 12(4)202–208
   PubMed Web of Science ®Google Scholar
• Foley KM, Inturrisi CE. Analgesic drug therapy in cancer pain: Principles and practice. Med Clin North Am 1987; 71: 207–232
   PubMed Web of Science ®Google Scholar
• Portenoy RK. Continuous intravenous infusion of opioid drugs. Med Clin North Am 1987; 71(2)233–241
   PubMed Web of Science ®Google Scholar
• Citron ML, Johnston-Early A, Fossieck BE, et al. Safety and efficacy of continuous intravenous morphine for severe cancer pain. Am J Med 1984; 77: 199–204
   PubMed Web of Science ®Google Scholar
• Kerr IG, Sone M, DeAngelis C, et al. Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients. Ann Intern Med 1988; 108: 554–557
   PubMed Web of Science ®Google Scholar
• Coyle N, Mauskop A, Maggard J, Foley KM. Continuous subcutaneous infusions of opiates in cancer patients with pain. Oncol Nurs Forum 1986; 13(4)53–57
   PubMedGoogle Scholar
• Moulin DE., Kreeft JH, Murray-Parsons N, Bouquillon AI. Comparisons of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain?. Lancet 1991; 1: 465–468
   Google Scholar
• Bromage PR, Camporesi E, Chestnut D. Epidural narcotics for postoperative analgesia. Anesth Analg 1980; 59: 473–480
   PubMed Web of Science ®Google Scholar
• Payne R. Role of epidural and intrathecal narcotics and peptides in the management of cancer pain. Med Clin North Am 1987; 71(2)313–327
   PubMed Web of Science ®Google Scholar
• Payne R, Inturrisi CE. CSF distribution of morphine. methadone and C14-sucrose after intmthecal injection. Life Sci 1985; 37: 1137–1144
   PubMed Web of Science ®Google Scholar
• Gourlay GK, Cherry DA, Cousins MJ. Cephalad migration of morphine in CSF following lumbar epidural administration in patients with cancer pain. Pain 1985; 23: 317–326
   PubMed Web of Science ®Google Scholar
• Gustafsson LL, Schildt B, Jacobsen K. Adverse effects of ex-tradural and intrathecal opioids: Report of a nationwide survey in Sweden. Br J Anaesth 1982; 54: 479–485
   PubMed Web of Science ®Google Scholar
• Behar M, Olshwant D, Magora E, et al. Epidural morphine in treatment of pain. Lancet 1979; 1: 527–529
   PubMed Web of Science ®Google Scholar
• Leavens ME, Hill CS, Cech DA, et al. lntrathecal and intraventricular morphine for pain in cancer paticnts: Initial study. J Neurosurg 1982; 56: 241–245
   PubMed Web of Science ®Google Scholar
• Greenberg HS, Taren J, Ensminger W, et al. Benefit lrorn and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain. J Neurosurg 1982; 57: 360–364
   PubMed Web of Science ®Google Scholar
• Coyle N. Continuity of care for the cancer patient with chronic pain. Cancer 63 1989; 2289–2293, Suppl 11
   Google Scholar